Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 99-104

  Summers, Roger J ^a   Bathgate, Ross A D ^b   Wade, John D ^b   Van Der Westhuizen, Emma T ^a   Halls, Michelle L ^a  

^a MONASH UNIVERSITY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

GPCR135; INSL3; LGR7; LGR8; Relaxin; Relaxin 3; RXFP1; RXFP2; RXFP3

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN RXFP1; PROTEIN RXFP2; PROTEIN RXFP3; PROTEIN RXFP4; UNCLASSIFIED DRUG;

ANIMAL CELL; CONFERENCE PAPER; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REPORTER GENE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 64549154880     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.03828.x     Document Type: Conference Paper

References (23)

1. Bathgate, R.A., R. Ivell, B.M. Sanborn, et al. 2006. International Union of Pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 58: 7-31.
2. Halls, M.L., R.A. Bathgate & R.J. Summers. 2006. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol. Pharmacol. 70: 214-226.
3. Nguyen, B.T. & C.W. Dessauer. 2005. Relaxin stimulates protein kinase C zeta translocation: Require-ment for cyclic adenosine 3',5'-monophosphate production. Mol. Endocrinol. 19: 1012-1023.
4. Liu, C., E. Eriste, S. Sutton, et al. 2003. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J. Biol. Chem. 278: 50754-50764.
5. Liu, C., J. Chen, S. Sutton, et al. 2003. Identification of relaxin-3/INSL7 as aligandfor GPCR142. J. Biol. Chem. 278: 50765-50770.
6. Van Der Westhuizen, E.T., T.D. Werry, P.M. Sexton, et al. 2007. The relaxin family peptide receptor 3 (RXFP3) activates ERK1/2 through a PKC dependent mechanism. Mol. Pharmacol. 71: 1618-1629.
7. Dschietzig, T., C. Bartsch, V. Stangl, et al. 2004. Identification of the pregnancy hormone relaxin as gluco-corticoid receptor agonist. FASEB J. 18: 1536-1538.
8. Bartsch, O., B. Bartlick & R. Ivell. 2001. Relaxin signalling links tyrosine phosphorylation to phospho-diesterase and adenylyl cyclase activity. Mol. Hum. Reprod. 7: 799-809.
9. Bartsch, O., B. Bartlick & R. Ivell. 2004. Phosphodi-esterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 89: 324-334.
10. Nistri, S. & D. Bani. 2003. Relaxin receptors and nitric oxide synthases: Search for the missing link. Reprod. Biol. Endocrinol. 1: 5.
11. Conrad, K.P. & J. Novak. 2004. Emerging role of relaxin in renal and cardiovascular function. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R250-R261.
12. Nguyen, B.T., L. Yang, B.M. Sanborn, et al. 2003. Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3',5'-monophosphate by relaxin. Mol. Endocrinol. 17: 1075-1084.
13. Kramer, S.M., U.E. Gibson, B.M. Fendly, et al. 1990. Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture. In Vitro Cell. Dev. Biol. 26: 647-656.
14. Hsu, C.J., S.M. McCormack & B.M. Sanborn. 1985. The effect of relaxin on cyclic adenosine 3',5'-monophosphate concentrations in rat myometrial cells in culture. Endocrinology 116: 2029-2035.
15. Sanborn, B.M., H.S. Kuo, N.W. Weisbrodt, et al. 1980. The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology 106: 1210-1215.
16. 125I-labeled relaxin and tissue changes in adenosine 3',5'-monophosphate levels after in vitro relaxin incubation. Endocrinology 106: 1203-1209.
17. Braddon, S.A. 1978. Relaxin-dependent adenosine 6',5'-monophosphate concentration changes in the mouse pubic symphysis. Endocrinology 102: 1292-1299.
18. Kompa, A.R., C.S. Samuel & R.J. Summers. 2002. Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): Ef-fect of pertussis toxin. Br. J. Pharmacol. 137: 710-718.
19. Parsell, D.A., J.Y. Mak, E.P. Amento, et al. 1996. Relaxin binds to and elicits a response from cells of the human monocytic cell line, THP-1. J. Biol. Chem. 271: 27936-27941.
20. Sato, M., T. Horinouchi, D.S. Hutchinson, et al. 2007. Ligand-directed signaling at the β3-adrenoceptor produced by 3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1 -ylamino] -2S-2-propanol oxalate (SR59230A) relative to receptor agonists. Mol. Phar-macol. 72: 1359-1368.
21. Kenakin, T.P. 2003. The secret lives of GPCRs. Drug Discov. Today 8: 674.
22. Liu, C., J. Chen, C. Kuei, et al. 2005. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol. Pharmacol. 67: 231-240.
23. Halls, M.L., R.A. Bathgate & R.J. Summers. 2007. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes. J. Pharmacol. Exp. Ther. 320: 281-290.